Ticagrelor Versus Cilostazol in Large-vessel Ischemic Stroke

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
Along with the current clinical trial, the efficacy and safety of 180 mg loading dose of ticagrelor administered within 24 hours of first-ever large-vessel ischemic stroke compared to 200 mg cilostazol were assessed through NIHSS, mRS, and possible adverse effects.
Epistemonikos ID: 4d5b286ab4790dabf4c7df099a5f93264bf11d9a
First added on: May 15, 2024